[1]朱静文,蒋桔泉.迷走神经干预在心血管疾病中的治疗作用[J].心血管病学进展,2020,(3):301-305.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.021]
 ZHU Jingwen,JIANG Juquan.Therapeutic Effect of Vagus Nerve Intervention in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(3):301-305.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.021]
点击复制

迷走神经干预在心血管疾病中的治疗作用()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年3期
页码:
301-305
栏目:
综述
出版日期:
2020-03-25

文章信息/Info

Title:
Therapeutic Effect of Vagus Nerve Intervention in Cardiovascular Disease
作者:
朱静文1 蒋桔泉2
(1.武汉科技大学医学院,湖北 武汉4300652.中部战区总医院心内科,湖北 武汉430070)
Author(s):
ZHU Jingwen1 JIANG Juquan2
(1.Medical School of Wuhan University of Science and Technology,Wuhan 430065,Hubei,China2.Department of Cardiology, Central War Zone General Hospital of PLA,Wuhan 430070,Hubei,China)
关键词:
心血管疾病迷走神经交感神经
Keywords:
Cardiovascular diseasesVagus nerveSympathetic nerve
DOI:
10.16806/j.cnki.issn.1004-3934.2020.03.021
摘要:
心脏自主神经系统主要由交感神经和迷走神经系统构成,其在心血管疾病的发生和发展中起到重要作用。大量动物实验和临床研究证实交感神经张力增高与多种疾病相关。近年来,迷走神经干预在心力衰竭、心律失常、血管迷走性晕厥和心血管炎症反应等心血管疾病中的治疗作用已得到证实。现就迷走神经干预在心血管疾病中的治疗作用做一综述。
Abstract:
Autonomic nervous system composed of sympathetic nerve and vagus nerve,it plays a critical role in the pathogenesis and development of cardiovascular diseases.It has been proved that the hyperactivity of sympathetic nerve contributes to the pathogenesis of the diseases in a great amount of trials in vitro and clinical practices.In recent years,it has also been confirmed that the role of vagal intervention in the treatment of cardiovascular diseases such as heart failure,arrhythmia,vasovagal syncope and cardiovascular inflammation.Here is to make a review of the therapeutic effect of vagus nerve intervention in cardiovascular diseases

参考文献/References:

[1]. 王振亚,江洪.自主神经再平衡与缺血性室性心律失常[J].心血管病学进展,2019,40(2):268-272.
[2]. Li M,Zheng C,Sato T,et al.Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats[J].Circulation,2004,109(1):120-124.
[3]. Sabbah HN,Ilsar I,Zaretsky A,et al.Vagus nerve stimulation in experimental heart failure[J].Heart Fail Rev,2011,16(2):171-178.
[4]. Zhang Y,Popovic ZB,Bibevski S,et al.Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model[J].Circ Heart Fail,2009,2(6):692-699.
[5]. Schwartz PJ,de Ferrari GM,Sanzo A,et al. Long term vagal stimulation in patients with advanced heart failure:first experience in man[J]. Eur J Heart Fail,2008,10(9):884-891.
[6]. de Ferrari GM,Crijns HJ,Borggrefe M,et al.Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure[J].Eur Heart J,2011,32(7):847-855.
[7]. Premchand RK,Sharma K,Mittal S,et al. Extended follow-up of patients with heart failure receiving autonomic regulation therapy in the ANTHEM-HF study[J]. J Card Fail,2016,22(8):639-642.
[8]. Hauptman PJ,Schwartz PJ,Gold MR,et al. Rationale and study design of the increase of vagal tone in heart failure study:INOVATE-HF[J]. Am Heart J,2012,163(6):954-962.
[9]. Zhou L,Filiberti A,Humphrey MB et al. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction[J].Exp Physiol,2019,104(1): 28-38.
[10]. 杜鑫,王玉堂,单兆亮,等.神经节消融治疗房颤的荟萃分析[J].解放军医学院学报,2014,35(6):600-604.
[11]. Pokushalov E,Romanov A,Corbucci G,et al.A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension[J].J Am Coll Cardiol,2012,60(13):1163-1170.
[12]. Katritsis DG,Pokushalov E,Romanov A,et al.Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation:a randomized clinical trial[J].J Am Coll Cardiol,2013,62(24):2318-2325.
[13]. Xu FQ,Yu RH,Guo JJ,et al.Catheter ablation of recurrent paroxysmal atrial fibrillation:is gap-closure combining ganglionated plexi ablation more effective?[J].Pacing Clin Electrophysiol,2017,40 (6):672-682.
[14]. He B,Lu Z,He W,et al.Effects of ganglionated plexi ablation on ventricular electrophysiological properties in normal hearts and after acute myocardial ischemia[J]. Int J Cardiol,2013,168(1):86-93.
[15]. 姜兆磊.自主神经系统与心房颤动的关系及房颤诊疗策略的研究[D].上海交通大学,2015.
[16]. Shen MJ,Chang HC ,Park HW,et al.Low-level vagus nerve stimulation upregulates small co-
[17].nductance calcium-activated potassium channels in the Stellate ganglion[J].Heart Rhythm,2013,10:910-
[18].915.
[19]. Yu L,Scherlag BJ,Li S,et al.Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve:a noninvasive approach to treat the initial phase of atrial fibrillation[J].Heart Rhythm,2013,10(3):428-435.
[20]. Stavrakis S,Humphrey MB,Scherlag BJ,et al. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation[J]. J Am Coll Cardiol,2015,65(9):867-875.
[21]. Vaseghi M,Salavatian S,Rajendran PS,et al.Parasympathetic dysfunction and antiarrhythmic effect of vagal nerve stimulation following myocardial infarction[J].JCI Insight,2017,2(16)pii:86715.
[22]. Yamaguchi N,Yamakawa K,Rajendran PS,et al.Anti-arrhythmic effects of vagal nerve stimulation after cardiac sympathetic denervation in the setting of chronic myocardial infarction[J].Heart Rhythm,2018,15
[23].(8):1214-1222.
[24]. Shinlapawittayatorn K,Chinda K,Palee S,et al. Vagus nerve stimulation initiated late during ischemia, but not reperfusion, exerts cardioprotection via amelioration of cardiac mitochondrial dysfunction[J].Heart Rhythm,2014,11(12):2278-2287.
[25]. 赵爽.神经调控在心脏性猝死预防中的作用及机制研究[D].北京协和医学院,2017.
[26]. Yu L,Huang B,Po SS,et al.Low-level tragus stimulation for the treatment of ischemia and reperfusion injury in patients with ST-segment elevation myocardial infarction:a proof-of-conceptstudy[J].JACC Cardiovasc Interv,2017,10(15):1511-1520.
[27]. Nasi-Er BG,Wenhui Z,HuaXin S,et al. Vagus nerve stimulation reduces ventricular arrhythmias and increases ventricular electrical stability[J].Pacing Clin Electrophysiol,2019,42(2):247-256.
[28]. 蒋桔泉,宋麒麟,丁世芳,等.急性ST段抬高型心肌梗死患者再灌注治疗前后心律失常与自主神经功能的关系[J].岭南心血管病杂志,2019,25(1):68-71,79.
[29]. Flaim SN,McCulloch AD,Acetylcholine-induced shortening of the epicardial action potential duration may increase repolarization gradients and LQT3 arrhythmic risk[J].J Electrocardiol,2007,40:(6 Suppl):S66-S69.
[30]. ]Mancia G,Fagard R, Narkiewicz K,et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension[J].Blood Press,2014,23(1):3-16.
[31]. Annoni EM,Xie X,Lee SW,et al.Intermittent electrical stimulation of the right cervical vagus nerve in salt-sensitive hypertensive rats:effects on blood pressure[J]. Physiol Rep ,2015,3(8).pii:e12476.
[32]. Plachta DT,Gierthmuehlen M,Cota O,et al. Blood pressure control with selective vagal nerve stimulation and minimal side effects[J].J Neural Eng,2014,11(3):036011.
[33]. Gierthmuehlen M,Plachta DT. Effect of selective vagal nerve stimulation on blood pressure,heart rate and respiratory rate in rats under metoprolol medication[J].Hypertens Res,2016,39(2):79-87.
[34]. Barbic F,Heusser K,Marchi A,et al.Cardiovascular parameters and neural sympathetic discharge variability before orthostatic syncope:role of sympathetic baroreflex control to the vessels[J].Physiol Meas,2015,36(4):633-641.
[35]. 中华心血管病杂志编辑委员会,中国生物医学工程学会心律分会,中国老年学和老年医学学会心血管病专业委员会,等.晕厥诊断与治疗中国专家共识(2018)[J].中华心血管病杂志,2019,47(2):96-107.
[36]. Aydin MA,Mortensen K,Salukhe TV,et al.A standardized education protocol significantly reduces traumatic injuries and syncope recurrence:an observational study in 316 patients with vasovagal syncope[J].Europace,2012,14(3):410-415.
[37]. Pachon MJC,Pachon MEI,Lobo TJ,et al. Syncopal high-degree AV block treated with catheter RF ablation without pacemaker implantation[J]. Pacing Clin Electrophysiol,2006,29(3):318-322.
[38]. Scanavacca M,Hachul D,Pisani C,et al. Selective vagal denervation of the sinus and atrioventricular nodes, guided by vagal reflexes induced by high frequency stimulation, to treat refractory neurally mediated syncope[J]. J Cardiovasc Electrophysiol,2009,20(5):558-563.
[39]. Rebecchi M,de Ruvo E,Strano S,et al.Ganglionated plexi ablation in right atrium to treat cardioinhibitory neurocardiogenic syncope[J]. J Interv Card Electrophysiol,2012,34(3):231-235.
[40]. 孙巍,郑黎晖,姚焰,等.左心房心内膜去神经化射频消融治疗难治性血管迷走性晕厥的安全性和有效性研究[J].中国循环杂志,2016,31(3):254-258.
[41]. Kong SS,Liu JJ,Hwang TC,et al.Tumour necrosis factor-alpha and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats[J].Clin Exp Pharmacol Physiol,2011,38(5):300-306.
[42]. He B,Lu Z,He W,et al.Low-intensity atrial ganglionated plexi stimulation decreases the serum level of inflammatory factors in canine[J].Heart Lung Circ,2015,24(4):407-410.
[43]. Leib C,G?ser S,Lüthje D,et al.Role of the cholinergic antiinflammatory pathway in murine autoimmune myocarditis[J].Circ Res,2011,109(2):130-140.
[44]. Li DL,Liu JJ,Liu BH,et al. Acetylcholine inhibits hypoxia-induced tumor necrosis factor-alpha production via regulation of MAPKs phosphorylation in cardiomyocytes[J]. J Cell Physiol,2011,226(4):1052-1059.

相似文献/References:

[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
 BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(3):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]王振,综述,惠杰,等.迷走神经刺激与心力衰竭[J].心血管病学进展,2016,(2):197.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.026]
 WANG Zhen,HUI Jie.Vagus Nerve Stimulation and Heart Failure[J].Advances in Cardiovascular Diseases,2016,(3):197.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.026]
[3]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
 REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(3):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[4]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
 YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(3):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[5]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
 ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(3):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[6]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
 QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(3):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[7]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
 JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(3):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[8]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[9]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
 HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(3):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[10]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
 Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(3):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]

备注/Memo

备注/Memo:
收稿日期:2019-09-10 通讯作者:蒋桔泉,E-mail:2258290767@qq.com
更新日期/Last Update: 2020-05-20